Conference Coverage

Abstracts Presented at the 2017 AVAHO Annual Meeting

September 15-17, 2017 Denver, CO


 

1. Veteran Satisfaction With Video-Based Telemedicine for Pre-Transplant Valuation

Hassler M, Ellis D, Hicks R, Chester H

2. Characterization of Hematology Consults for Complete Blood Count Abnormalities: A Single Center Experience in the Era of Electronic Consultation

Barth P, Freeman N, Faricy-Anderson K

3. Recurrent Cisplatin Hypersensitivity Reaction After First Exposure: A Case Report

Solomon BL, Colonna SV

4. The Role of Academic Affiliation in the Treatment of Metastatic Castrate-Resistant Prostate Cancer in the Veterans Health Administration

Rasmussen KM, Patil V, Burningham Z, Narayanan S, Lin S-W, Carroll S, Hsu LL, Graff JN, Dreicer R, Gupta S, Low C, Sauer BC, Halwani A

5. Comorbidity and Survival With Receipt of Adjuvant Immunotherapy in Stage III Melanoma: An Analysis of the National Cancer Database

Satish M, Walters R, Silberstein P

6. Improving Access and Workflow in Radiation Oncology in an Attempt to Decrease Time Between Cancer Diagnosis and First Treatment

Fosmire H, Shapiro R, Dreshar C, Hale A, Holliday J, Horn M, Hunt T

7. Failure Patterns After Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer and Their Implications for Future Management

Bhandari RP, Giri SP, Kumar PP, He R

8. Comparison of PFT Before and After Radiation Therapy for Lung Cancer

Giri SP, Kumar PP, Johnson SD

9. Using Natural Language Processing in Radiology Reports to Identify the Presence of Metastatic Disease in Veterans With Prostate Cancer

Patil V, Rasmussen KM, Burningham Z, Low C, Gupta S, Sauer BC, Halwani A

10. Examining Methods for Systematically Identifying Cytogenetic Testing Among Chronic Lymphoblastic Leukemia Patients

Halwani A, Rasmussen KM, Patil V, Burningham Z, Low C, Meissner B, Kapustyan T, Keim H, Lawrence N, Walker J, Sauer BC

11. Breast Cancer Risk Assessment and Chemoprevention Use Among VA Primary Care

Merriman J, Bidassie B, Kovach A, Vallette MA, Park YHA, Aggarwal A, Colonna SV

12. National Comprehensive Cancer Network Distress Thermometer Versus Veteran Symptom Assessment Screen: Year in Review at the Cleveland VAMC

Smith J, Arfons L, Cmolik B, Fox D, Dimick J, Berman S, Woods K, Simon J

13. A Veterans Affairs Experience: An Infusion Room Model Incorporating Advanced Hematology Oncology Fellows

Farooqi B, Close J, Duff J

14. Life-Sustaining Treatment Initiative

Blakowski S

15. Hypertension Among Veterans Affairs Colorectal Cancer Survivors: A Matched Case-Control Analysis

Zullig LL, Lindquist J, Smith VA, Williams CD, Weinberger M, Povenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB

16. Automation of Cancer Surveillance Care: Using Technology to Improve Outcomes of Care

Schwartz J, Valdez-Boyle L, Speed W, Garcia M, DeHerrera M, Schneider S, Chavez R, Wehner S, Flores B, Garcia D

17. Sustained Effects of Oncology Drug Cost Savings Initiatives: A VA Medical Center Outpatient Oncology Clinic Experience

O’Hearn J, Szczapinski R, Hendler FJ

18. Two Somatic P53 Mutations, Two Histological Tumors From Single Founder Clone: A Conglomerate of Pituitary Corticotropinoma and Rhabdomyosarcoma

Kommalapati A, Zhao C, Tella SH

19. Is Hypomagnesemia a Marker of Efficacy of Cetuximab in Locoregionally Advanced and Metastatic Head and Neck Cancer?

Azar I, Assi H, Esfandiarifard S, Asrani R, Mehdi S

20. Sunitinib-Induced Acute Intestinal Nephritis

Azar I, Assi H, Esfandiarifard S, Asrani R, Sinai P, Foulke L, Mehdi S

21. High-Quality Patient-Centered Care for the Rural Veteran With Cancer

Ruiz J, Seegars MB

22. CK2 Correlates With Overall and Progression-Free Survival in Oropharyngeal Squamous Cell Carcinoma

Klein M, Li B, Peltola J, Trembley MJ, Ahmed K, Caicedo-Granados E

23. Evaluating Psychsocial Distress in Veterans and Their Caregivers at the Palo Alto VA

McCallion EA, Dodd SM, Chwick K, Ivan I, Wong S, Pan T, Yang J, Shindel C, Carson R

24. How Can VA Optimize Palliative Oncology Care? Updates on AVAHO Palliative Care Research Committee Projects

Faricy-Anderson K, Crawford R, Lee S, Blakowski S, McDermott J, Chang V, Cullen G, Lapsiwala R, Henry E, Berlin K, Cassel JB, Conner A, Moghanaki D

25. Cancer Fast Track e-Consults: An Innovative Approach to e-Consultation

Arfons L, Curry S, Nock C, Smith J, Woods K

26. A Rare Case of Sunitinib-Induced Rhabd omyolysis in Renal Cell Carcinoma at VA Pittsburgh Healthcare System

Liman A, Shields J, Passero V

27. Anti-CD20 Antibody Order Check s and Medication Use Evaluation Tracker Increase Hepatitis B Testing and Antiviral Treatment in VHA

Hammond JM, Kelley MJ, Cunningham F, Volpp BD, Lowy E, Beste LA, Bullard AJ, Heron BB, Geraci MC, Aytaman A, LaPlant KD, Britt RB, O’Leary MC, Turner MJ, Hunt CM

28. Electronic Consultation: An Efficient and Effective Way to Manage Hematology Consults

Arfons L

29. Application of Extracellular Matrix to Reinforce Bowel Anstomoses in Colorectal Surgery: Does It Make a Difference in Clinically Significant Leaks?

Valdez-Boyle L, Schwartz J

30. Evaluation of Fitness, Metabolism, and Quality of Life During Hematopoietic Stem Cell Transplant

Graf SA, Anderson LJ, Crabtree SA, Migula D, Paski SC, Chauncey TR, Garcia JM

31. Update on the VA Precision Oncology Program

Hintze BJ, Duffy JE, Williams CD, Spector NL, Kelley MJ

32. Overview of Oral Oncolytic Processes at Iowa City VAHCS Oncology Clinic

Tague M, Egge J

33. Post-Treatment Follow-Up by Oncologic Specialists as a Relevant Component of Cancer Survivorship for Veteran Patients Living in Rural Area

Lee SP, Cho-Lim JJ, Inouye WS

34. A Case of Mytomycin-C-Induced Pulmonary Veno-Occlusive Disease

Thibault J, Patel S

35. Successful 3-Year Melanoma Treatment After Nivolumab Failure

Lepir T, Savaraj N

36. Metabolic Reprogramming in BRAF Inhibitor-Resistant Melanoma Cells Leads to Hypersensitvity to Arginine Depletion and Upregulation of PD-L1 Expression

Savaraj N, Li YY, Wu C, Suarez M, Shah SS, Chen SM, Wangpaichitr M, Kuo MT, Feun LG

37. Navigator Driven Process to Coordinate Multi-Disciplinary Visits for Advanced Lung Cancer Patients

Nelson K, Mariash E, Smith J

38. Assessing the Efficacy of Prostate Cancer Therapies in Veterans at the James J. Peters VAMC

Hsu TM, Leuva H, Wilkerson J, Sigel K, Patel I, Anderson C, McWilliams GW, Park YHA, Bates S, Fojo T

39. Addressing Barriers to Cancer Care: An Interdisciplinary Team Approach to Patient Navigation

Slind L, Keating T, Fisher A

40. Structuring Data to Automate Cancer Survivorship Care Plans

Hamilton-Hill S, Kelley MJ, Duffy JE

41. Combining Chemotherapy and Trastuzimab in Patients With HER2/Neu-Positive Metastatic Salivary Gland Carcinoma

Arekapudi S, Thomas SP

42. Cisplatin Ototoxicity: Evidence for Dosing Effect on the Risk of Hearing Shifts Among Head and Neck Cancer Patients Receiving Chemoradiation

Maggiore RJ, Bennett KO, Konrad-Martin D, McMillan GP, Lyle SW, Rana SR, Dille M

43. Efficacy and Toxicity of XELOX vs FOLFOX in Adjuvant and Metastatic Treatment of Colorectal Cancer in Veterans

Crawford R, Banaszynski M, Cushing M, Truong T

44. Systemic and Tumor Directed Therapy for Oligometastic Prostate Cancer

Nickols NG, Rettig MB, Garraway IP, Lewis M, Tomlinson JS, Lee SP, Jordan ML

45. Incorporating Survivorship Care Plans Into Practice

Jasti P, Cullen G, Fontes G, Rechel C, Benacquisto T, van Zyl R

46. Abdominal Compression by Prone Position in Lung SBRT—A Technical Note

Reddy E

47. When Genetic Testing Is Not the Best Care Anywhere

Venne VL, Anderson JL, Hartzfeld DE, Hummel SD, Morris BL, Morrison VA, Rider RA, Tsuyuki A

48. Differential Response to Carfilzomib Based on Initial Therapy With Bortezomib in Multiple Myeloma

Ifeorah C, Fletcher L, Rivero G, Yasin Z, Krieger J, Mulchandani A, Catic A, Mims MP, Yellapragada S

49. Quality Analysis of Molecular Turnaround Times and Process Completion Times for In-House Testing

Gruenberg J, Manivel JC

50. Staging and Survival of Colorectal Cancer in Octogenarians: Nationwide Study of U.S. Veterans

Virk G, Jafri M, Ashley C, Mehdi S

51. Evaluation of Oncologic Pharmacotherapy and Implementation of a Pharmacist-Managed Monitoring Protocol at a Community-Based Outpatient Clinic

Arnhoelter K, Jacob J, Bloesl R

52. Treatment Rates and Outcomes for Patients With Metastatic Pancreatic Cancer at a Single VA Hospital: An Exploratory Analysis

Wazir A, Azar I, Mehdi S

53. Improving Access to Care and Patient Satisfaction With Disease-Specific Colorectal Cancer Navigation

Mertz AB, Oakes RS, Burnell MD, Feiler MM, Thienelt CD, McDermott JD, Klein CE, Bowles DW

54. Types of Cancer Patients Who Enroll in the MyHealtheVets Online Patient Portal

Haggstrom D

55. A Novel Genetic Marker Has Been Identified in Patients With Fluoroquinolone-Associated Neuropsychiatric Toxicity: Preliminary Findings

Bennett A, Qureshi ZP, Bennett CL

Recommended Reading

How Can VA Expand Best Practices in Cancer Care?
AVAHO
Shorter Length of Stay May Not Mean Higher Readmission Rates
AVAHO
Get to Know the Trump Administration VA Secretary Nominee
AVAHO
A Call for Optimizing the Research Portfolio for Glioblastoma
AVAHO
Rare Cancer Gets Timely Right Treatment
AVAHO
Metastasized Renal Cell Cancer in Remission With Sunitinib
AVAHO
Elder Patients With Diabetes at Higher Risk for Cancer Surgery
AVAHO
Quality Analysis of Molecular Turnaround Times and Process Completion Times for In-House Testing
AVAHO
Evaluation of Oncologic Pharmacotherapy and Implementation of a Pharmacist-Managed Monitoring Protocol at a Community-Based Outpatient Clinic
AVAHO
Types of Cancer Patients Who Enroll in the MyHealtheVets Online Patient Portal
AVAHO